This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Reports
Country profiles
Clinical Excellence
Cardiology
Respiratory
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Oncology
Warning as skin cancer rates double in 20 years
Read more
Spectrila enters the UK market for the treatment of acute lymphoblastic leukaemia
Read more
Neuroendocrine tumour service named as Centre of Excellence
Read more
Firmagon® recommended for advanced prostate cancer with spinal metastases
Read more
European Commission approves extended indication for Kyprolis® for relapsed multiple myeloma patients
Read more
Updated NICE quality standard recommends Oncotype DX® in early-stage breast cancer
Read more
Meeting cancer promises and more – a new model for NHS diagnostics?
Read more
Blincyto® improved overall survival in patients with B-cell precursor acute lymphoblastic leukaemia
Read more
Merck partners with Array BioPharma and Pierre Fabre to initiate BRAF-mutant CRC trial
Read more
Amgen receives positive CHMP opinion to extend indication of Kyprolis®
Read more
NICE recommends Jevtana® to treat eligible patients with advanced prostate cancer
Read more
Latest developments in intravascular robotics
Read more
A novel therapy for high-grade glioma
Read more
AbbVie announces The Lancet Oncology publication of Phase II data for Venetoclax
Read more
Managing chemotherapy extravasations in practice
Read more
Urine FISH for detection of urothelial cancer
Read more
MALDI-MSI: a powerful tool in cancer research
Read more
Page 29 of 37
« First
«
...
10
20
...
27
28
29
30
31
...
»
Last »
Popular articles
Does cancer screening actually reduce all-cause mortality?
25 September, 2023
Stress and high workload confirmed as main reasons staff leave NHS
25 September, 2023
Ruxolitinib approved by NICE for treatment of polycythaemia vera
25 September, 2023
×
Search for: